ConductScience.org, home

Paper41255464

Nanomaterials for Theranostic Management of Oral Cancer: Advances in Imaging, Biosensing, Targeted Delivery, and Multimodal Synergistic Therapy.

Zhu X and 4 others. Int J Nanomedicine, 2025. Cited by 6 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Nanomaterials for Theranostic Management of Oral Cancer: Advances in Imaging, Biosensing, Targeted Delivery, and Multimodal Synergistic Therapy. Papers, record 41255464. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41255464

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Nanomaterials for Theranostic Management of Oral Cancer: Advances in Imaging, Biosensing, Targeted Delivery, and Multimodal Synergistic Therapy.
PubMed
Journal
Int J Nanomedicine
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
2.09, provisional
iCite
Revised in PubMed
2025-11-21
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhu XXingcheng
2Chen JJunhaohttps://orcid.org/0009-0006-4850-6790
3Zhao JJunxian
4Zhang ZZhongsonghttps://orcid.org/0009-0009-9465-6425
5Wang CChengjiehttps://orcid.org/0009-0009-8882-0823

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Mouth NeoplasmsMajor topic
Theranostic NanomedicineMajor topic
NanostructuresMajor topic
Carcinoma, Squamous CellMajor topic
Humans
Drug Delivery Systems
Combined Modality Therapy
Biosensing Techniques
Animals
Photochemotherapy
Genetic Therapy

Source PubMed

Download CSV of topics

References258

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
140285805Innovative nanoparticle strategies for treating oral cancers.Med Oncol2025https://conductscience.org/library/papers/40285805PubMed
237547360Nanoplatforms: The future of oral cancer treatment.Health Sci Rep2023https://conductscience.org/library/papers/37547360PubMed
336971908Oral delivery of RNAi for cancer therapy.Cancer Metastasis Rev2023https://conductscience.org/library/papers/36971908PubMed
440682120Delivery of an ERK inhibitor using bioactive lipid nanoparticles reduces angiogenesis and prevents oral squamous cell carcinoma development.J Nanobiotechnology2025https://conductscience.org/library/papers/40682120PubMed
534976214Repurposing ferumoxytol: Diagnostic and therapeutic applications of an FDA-approved nanoparticle.Theranostics2022https://conductscience.org/library/papers/34976214PubMed
636079307Graphene Nanostructures by Pulsed Laser Ablation in Liquids: A Review.Materials (Basel)2022https://conductscience.org/library/papers/36079307PubMed
739902172Harnessing nanotechnology for cancer treatment.Front Bioeng Biotechnol2024https://conductscience.org/library/papers/39902172PubMed
839501968Advanced Nanomaterials for Cancer Therapy: Gold, Silver, and Iron Oxide Nanoparticles in Oncological Applications.Adv Healthc Mater2025https://conductscience.org/library/papers/39501968PubMed
936923400The development of highly dense highly protected surfactant ionizable lipid RNA loaded nanoparticles.Front Immunol2023https://conductscience.org/library/papers/36923400PubMed
1037971722Nivolumab for Patients With High-Risk Oral Leukoplakia: A Nonrandomized Controlled Trial.JAMA Oncol2024https://conductscience.org/library/papers/37971722PubMed
1139467056Protecting Against Postsurgery Oral Cancer Recurrence with an Implantable Hydrogel Vaccine for In Situ Photoimmunotherapy.Adv Sci (Weinh)2024https://conductscience.org/library/papers/39467056PubMed
1240075499Harnessing the power of traceable system C-GAP: homologous-targeting to fire up T-cell immune responses with low-dose irradiation.J Nanobiotechnology2025https://conductscience.org/library/papers/40075499PubMed
1332984600Prospects of nanodentistry for the diagnosis and treatment of maxillofacial pathologies and cancers.Heliyon2020https://conductscience.org/library/papers/32984600PubMed
1436568302Editorial: Synthesis, functionalization, and clinical translation of pharmaceutical biomaterials.Front Bioeng Biotechnol2022https://conductscience.org/library/papers/36568302PubMed
1533096430One-step quantification of salivary exosomes based on combined aptamer recognition and quantum dot signal amplification.Biosens Bioelectron2021https://conductscience.org/library/papers/33096430PubMed
1633462277Graphene oxide loaded with tumor-targeted peptide and anti-cancer drugs for cancer target therapy.Sci Rep2021https://conductscience.org/library/papers/33462277PubMed
1738275722The Golgi Apparatus as an Anticancer Therapeutic Target.Biology (Basel)2023https://conductscience.org/library/papers/38275722PubMed
1837628860Current Advances in the Biomedical Applications of Quantum Dots: Promises and Challenges.Int J Mol Sci2023https://conductscience.org/library/papers/37628860PubMed
1935057015Combinatorial Therapeutic Approaches with Nanomaterial-Based Photodynamic Cancer Therapy.Pharmaceutics2022https://conductscience.org/library/papers/35057015PubMed
2039634304Carbon nanomaterials for phototherapy.Nanophotonics2022https://conductscience.org/library/papers/39634304PubMed

See all 258 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
42866938TOMM5 is associated with oral cancer progression: a multi-omics analysis from single-cell atlas to in vitro validation.Future Sci OA2026https://conductscience.org/library/papers/42866938PubMed
42449634Current Trends in Diagnosis and Early Monitoring of Oral Cavity Cancer: Techniques and Biomarkers.Cancers (Basel)2026https://conductscience.org/library/papers/42449634PubMed
41769336Metabolic crosstalk between oral microbiota and the host in OSCC: emerging roles of microbial metabolites in tumor initiation and progression.Front Cell Infect Microbiol2026https://conductscience.org/library/papers/41769336PubMed
41465540Holography Meets Theranostics: DFT/TDDFT Insights into Ru-NO@M20 (M = Au, Ag) and Ru-NO@Au10Ag10(Pc) Nanohybrids as Phase-Switchable Molecular Devices.Int J Mol Sci2025https://conductscience.org/library/papers/41465540PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41255464

GET https://conductscience.org/api/papers/v1/41255464/references?page=2